Data on the effects of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on intraocular pressure of ocular normotensive rats

QR Code

Data on the effects of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on intraocular pressure of ocular normotensive rats

This data is to document the intraocular pressure (IOP) lowering activity of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds in ocular normotensive rats. Effects of single drop application of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on IOP in ocul...

Full description

Bibliographic Details
Published in:	Data in Brief
Main Author:	Marcus A.J.; Iezhitsa I.; Agarwal R.; Vassiliev P.; Spasov A.; Zhukovskaya O.; Anisimova V.; Mohd Ismail N.
Format:	Data paper
Language:	English
Published:	Elsevier Inc. 2018
Online Access:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044521640&doi=10.1016%2fj.dib.2018.03.019&partnerID=40&md5=9e11e7e1387f8f1e11245d2583ad57c1

Similar Items

Intraocular pressure lowering effect and structure-activity relationship of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds in ocular normotensive rats: Insight on possible link with hypotensive activity
by: Marcus A.J.; Iezhitsa I.; Agarwal R.; Vassiliev P.; Spasov A.; Zhukovskaya O.; Anisimova V.; Johari B.; Mohd Ismail N.
Published: (2018)

Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension
by: Marcus A.J.; Iezhitsa I.; Agarwal R.; Vassiliev P.; Spasov A.; Zhukovskaya O.; Anisimova V.; Ismail N.M.
Published: (2019)

Synthesis of new 1,2-disubstituted benzimidazole analogs as potent inhibitors of β-Glucuronidase and in silico study
by: Taha M.; Ahmad Khan A.; Rahim F.; Imran S.; Salahuddin M.; Uddin N.; Mohammed Khan K.; Adnan Ali Shah S.; Zafar A.; Amiruddin Zakaria Z.
Published: (2022)

2-(2′-Pyridyl) benzimidazole derivatives and their urease inhibitory activity
by: Saify Z.S.; Kamil A.; Akhtar S.; Taha M.; Khan A.; Khan K.M.; Jahan S.; Rahim F.; Perveen S.; Choudhary M.I.
Published: (2014)

Synthesis, antimicrobial and cytotoxic evaluation of 4-(1-aryl-5-halo-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides
by: Kumar M.; Narasimhan B.; Ramasamy K.; Mani V.; Mishra R.K.; Majeed A.B.A.
Published: (2017)

Dataset of spectroscopic, crystallography and DFT of novel 1,2-bis[N,N’-6-(4-pyridylmethylamido)pyridyl-2-carboxyamido]butane
by: Kadir M.A.; Haris N.S.H.; Yusof M.S.M.; Kassim K.; Abdul Razak F.I.
Published: (2023)

Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N′-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxides
by: Saddique F.A.; Zaib S.; Jalil S.; Aslam S.; Ahmad M.; Sultan S.; Naz H.; Iqbal M.; Iqbal J.
Published: (2018)

Synthesis and α-glucosidase inhibition activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2h-benzo[e][1,2]thiazin-2-yl]-n-arylacetamides: An in silico and biochemical approach
by: Saddique F.A.; Aslam S.; Ahmad M.; Ashfaq U.A.; Muddassar M.; Sultan S.; Taj S.; Hussain M.; Lee D.S.; Zaki M.E.A.
Published: (2021)

Synthesis, antimicrobial, anticancer, antiviral evaluation and QSAR studies of 4-(1-aryl-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides
by: Kumar M.; Ramasamy K.; Mani V.; Mishra R.K.; Majeed A.B.A.; Clercq E.D.; Narasimhan B.
Published: (2014)

2-(2'-pyridyl) benzimidazole analogs and their ß-glucuronidase inhibitory activity
by: Kamil A.; Akhtar S.; Noureen S.; Saify Z.S.; Jahan S.; Khan K.M.; Rahim F.; Taha M.; Mushtaq N.; Arif M.; Perveen S.; Chaudhary M.I.
Published: (2015)

4-(1-Aryl-5-chloro-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides: Synthesis, antimicrobial, anticancer evaluation and QSAR studies
by: Kumar M.; Narasimhan B.; Kumar P.; Ramasamy K.; Mani V.; Mishra R.K.; Majeed A.B.A.
Published: (2014)

Synthesis of 2-phenyl-1H-imidazo[4,5-b]pyridine as type 2 diabetes inhibitors and molecular docking studies
by: Taha M.; Ismail N.H.; Imran S.; Ainaa I.; Selvaraj M.; baharudin M.; Ali M.; Khan K.M.; Uddin N.
Published: (2017)

Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension
by: Razali N.; Agarwal R.; Agarwal P.; Kumar S.; Tripathy M.; Vasudevan S.; Crowston J.G.; Ismail N.M.
Published: (2015)

Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
by: Zawawi N.K.N.A.; Taha M.; Ahmat N.; Wadood A.; Ismail N.H.; Rahim F.; Ali M.; Abdullah N.; Khan K.M.
Published: (2015)

Electrical transport and low-field magnetoresistance properties of (La 1-xYbx)2/3Ca1/3MnO3 (x=0 to 0.12) ceramics
by: Aini N.A.; Yusof M.I.M.; Huda N.; Mohamed Z.; Yahya A.K.
Published: (2009)

Pediococcus acidilactici LAB4 and Lactobacillus plantarum LAB12 assimilate cholesterol and modulate ABCA1, CD36, NPC1L1 and SCARB1 in vitro
by: Lim F.T.; Lim S.M.; Ramasamy K.
Published: (2017)

Synthesis and characterization of oxadiazole derivatives from benzimidazole; [Sintesis dan perincian terbitan oksadiazol dari benzimidazol]
by: Ahmat N.; Zawawi N.K.N.A.; Taha M.; Ismail N.H.; Abdullah N.
Published: (2016)

Synthesis and biological profile of substituted benzimidazoles
by: Vashist N.; Sambi S.S.; Narasimhan B.; Kumar S.; Lim S.M.; Shah S.A.A.; Ramasamy K.; Mani V.
Published: (2018)

Pyrimidine derivatives of n-acetylguanidine: Novel inhibitors of sodium-hydrogen exchanger 1
by: Ozerov A.; Novikov M.; Spasov A.; Iezhitsa I.; Gurova N.; Gurova V.
Published: (2018)

Chromium substituted liSn2P3O12 solid electrolyte
by: Norhaniza R.; Subban R.H.Y.; Mohamed N.S.; Ahmad A.
Published: (2012)

The Stimulus Factors Influencing Intention to Participate in Shopping during the Distribution of the 12.12 Online Shopping Festivals in Malaysia
by: Mahmuddin Y.; Abdullah M.; Ramdan M.R.; Anim N.A.H.M.; Aziz N.A.A.; Aziz N.A.A.; Yahaya R.; Aziz N.N.A.
Published: (2022)

Synthesis, X-ray crystal and monoamine oxidase inhibitory activity of 4,6-dihydrobenzo[c]pyrano[2,3-e][1,2]thiazine 5,5-dioxides: In vitro studies and docking analysis
by: Ahmad S.; Jalil S.; Zaib S.; Aslam S.; Ahmad M.; Rasul A.; Arshad M.N.; Sultan S.; Hameed A.; Asiri A.M.; Iqbal J.
Published: (2019)

A streamlined strategy for self-production of a commercial positive selection vector, the pJET1.2/blunt cloning vector, using common laboratory E. coli strains
by: Nawawi O.; Abdullah M.P.; Yusuf C.Y.L.
Published: (2023)

Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies
by: Taha M.; Ismail N.H.; Imran S.; Rashwan H.; Jamil W.; Ali S.; Kashif S.M.; Rahim F.; Salar U.; Khan K.M.
Published: (2016)

Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors
by: Taha M.; Ismail N.H.; Imran S.; Selvaraj M.; Rashwan H.; Farhanah F.U.; Rahim F.; Kesavanarayanan K.S.; Ali M.
Published: (2015)

Systematic characterization and comparison of the CYP2C9 variability of the Orang Asli in Malaysia with 12 populations
by: Teh L.K.; Subramaniam V.; Tuan Abdu Aziz T.A.; Lee L.S.; Ismail M.I.; Yu C.Y.; Ang G.Y.; James Johari R.; Ismet R.I.; Sahak N.S.; Ahmad A.; Rahman T.A.; Nor @ Ghazali F.M.; Shaari S.; Omar M.; Ismail A.I.; Md. Isa K.; Salleh H.; Salleh M.Z.
Published: (2016)

Syntheses, in vitro evaluation and molecular docking studies of 5-bromo-2-aryl benzimidazoles as α-glucosidase inhibitors
by: Arshad T.; Khan K.M.; Rasool N.; Salar U.; Hussain S.; Tahir T.; Ashraf M.; Wadood A.; Riaz M.; Perveen S.; Taha M.; Ismail N.H.
Published: (2016)

Role of TGF-β1/SMADs signalling pathway in resveratrol-induced reduction of extracellular matrix deposition by dexamethasone-treated human trabecular meshwork cells
by: Bakar A.S.A.; Razali N.; Agarwal R.; Iezhitsa I.; Perfilev M.A.; Vassiliev P.M.
Published: (2024)

5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α-glucosidase and urease enzymes
by: Arshad T.; Khan K.M.; Rasool N.; Salar U.; Hussain S.; Asghar H.; Ashraf M.; Wadood A.; Riaz M.; Perveen S.; Taha M.; Ismail N.H.
Published: (2017)

Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies
by: Zawawi N.K.N.A.; Taha M.; Ahmat N.; Wadood A.; Ismail N.H.; Rahim F.; Azam S.S.; Abdullah N.
Published: (2016)

5,8-Dihydroxy-2,2-dimethyl-12-(3-methylbut-2-enyl)pyrano[3,2-b]xanthen-6-one (brasixanthone B)
by: Binti Seruji N.M.U.; Rosli M.M.; Jong V.Y.M.; Karunakaran T.; Lizazman M.A.; Marlina A.; Binti Halid Y.Y.
Published: (2023)

New indolizidine alkaloids from psychrophilic yeast Glyciozyma antarctica PI12; [Alkaloid indolizidin baharu daripada Yis Psikrofilik Glyciozyma antarctica PI12]
by: Rosandy A.R.; Nadarajah W.; Bakar M.A.; Kqueen C.Y.; Mohd. Said M.I.; Al Muqarrabun L.M.R.; Khalid R.
Published: (2016)

Synthesis, molecular docking studies of hybrid benzimidazole as α-glucosidase inhibitor
by: Zawawi N.K.N.A.; Taha M.; Ahmat N.; Ismail N.H.; Wadood A.; Rahim F.
Published: (2017)

Synthesis of benzimidazole derivatives and their antiglycation, antioxidant, antiurease and molecular docking study
by: Taha, et al.
Published: (2024)

Synthesis of benzimidazole derivatives and their antiglycation, antioxidant, antiurease and molecular docking study
by: Taha M.; Rahim F.; Adalath B.; Imran S.; Mohammed Khan K.; Adnan Ali shah S.; Uddin N.; Nawaz M.; Break M.K.B.; Magam S.M.; Alqarni S.
Published: (2024)

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
by: Tahlan S.; Kumar S.; Ramasamy K.; Lim S.M.; Shah S.A.A.; Mani V.; Narasimhan B.
Published: (2019)

Development of N-alkylated benzimidazole based cubosome hydrogel for topical treatment of burns
by: Nawaz M.; Hayat S.; Farooq U.; Iqbal M.A.; Khalid S.H.; Nee T.W.; Khaw K.Y.; Munir R.; Ijaz M.U.
Published: (2024)

Synthesis, in vitro urease inhibitory potential and molecular docking study of Benzimidazole analogues
by: Zaman K.; Rahim F.; Taha M.; Ullah H.; Wadood A.; Nawaz M.; Khan F.; Wahab Z.; Shah S.A.A.; Rehman A.U.; Kawde A.-N.; Gollapalli M.
Published: (2019)

Benzimidazole derivatives protect against cytokine-induced apoptosis in pancreatic β-Cells
by: Zawawi N.K.N.A.; Rajput S.A.; Taha M.; Ahmat N.; Ismail N.H.; Abdullah N.; Khan K.M.; Choudhary M.I.
Published: (2015)

Development of N-alkylated benzimidazole based cubosome hydrogel for topical treatment of burns
by: Nawaz, et al.
Published: (2024)